Divi's Laboratories Ltd (DIVISLAB)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description-A detailed description of the company's operations and business divisions.
- Corporate strategy-Analyst's summarization of the company's business strategy.
- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history-Progression of key events associated with the company.
- Major products and services-A list of major products, services and brands of the company.
- Key competitors-A list of key competitors to the company.
- Key employees-A list of the key executives of the company.
- Executive biographies-A brief summary of the executives' employment history.
- Key operational heads-A list of personnel heading key departments/functions.
- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities-A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Divi's Laboratories Ltd (Divi's) is a pharmaceutical company which manufactures a broad range Active Pharmaceutical Ingredients (APIs) and intermediates. The product portfolio of the company includes generic APIs, nutraceuticals, custom synthesis of APIs, intermediates and specialty ingredients. The company operates across several countries in Europe and America. It operates manufacturing and research and development units in Hyderabad and Visakhapatnam, India. Divi's is headquartered in Hyderabad, Telangana, India.
Divi's Laboratories Ltd Key Recent Developments
May 16,2018: Divi's Laboratories: US-FDA Inspection of Unit -I at Choutuppal, Telangana State
Jan 27,2018: Divi's Labs earns Profit after Tax of Rs.225 crores in Q3/FY18
Nov 18,2017: EIR From US-FDA Received for Unit-II at Visakhapatnam
Nov 14,2017: Divi's Laboratories: Update on lifting of Import Alert 66-40 by US-FDA
Nov 02,2017: Divi's Laboratories: Update by USFDA on Unit-II at Visakhapatnam
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1-About the Company 5
Divi's Laboratories Ltd-Key Facts 5
Divi's Laboratories Ltd-Key Employees 6
Divi's Laboratories Ltd-Key Employee Biographies 7
Divi's Laboratories Ltd-Major Products and Services 8
Divi's Laboratories Ltd-History 9
Divi's Laboratories Ltd-Company Statement 10
Divi's Laboratories Ltd-Locations And Subsidiaries 11
Head Office 11
Other Locations & Subsidiaries 11
Section 2-Company Analysis 12
Company Overview 12
Divi's Laboratories Ltd-Business Description 13
Divi's Laboratories Ltd-Corporate Strategy 14
Divi's Laboratories Ltd-SWOT Analysis 15
SWOT Analysis-Overview 15
Divi's Laboratories Ltd-Strengths 15
Divi's Laboratories Ltd-Weaknesses 16
Divi's Laboratories Ltd-Opportunities 17
Divi's Laboratories Ltd-Threats 18
Divi's Laboratories Ltd-Key Competitors 19
Section 3-Company Financial Ratios 20
Financial Ratios-Capital Market Ratios 20
Financial Ratios-Annual Ratios 21
Performance Chart 24
Financial Performance 24
Financial Ratios-Ratio Charts 25
Section 4-Company's Recent Developments 26
May 16, 2018: Divi's Laboratories: US-FDA Inspection of Unit -I at Choutuppal, Telangana State 26
Nov 18, 2017: EIR From US-FDA Received for Unit-II at Visakhapatnam 27
Nov 14, 2017: Divi's Laboratories: Update on lifting of Import Alert 66-40 by US-FDA 28
Nov 02, 2017: Divis Laboratories: US-FDA Inspection of Unit -II 29
Sep 20, 2017: Divi's Laboratories: Update on USFDA for Unit-II at Visakhapatnam 30
Jul 22, 2017: Divi's Labs earns a total income of Rs. 851 crores for Q1 of FY18 31
Jul 22, 2017: Divi's Laboratories : Outcome of Board meeting-Appointment of Director 32
Jul 10, 2017: Divi's Laboratories: Update on Unit-II at Visakhapatnam 33
Mar 22, 2017: Divis Laboratories Provides an Update on FDA Import Alert 34
Mar 22, 2017: Divis Laboratories Provides an Update on FDA Import Alert 35
Section 5-Appendix 36
Ratio Definitions 36
About GlobalData 40
Contact Us 40
List of Figures
Divi's Laboratories Ltd, Performance Chart (2014-2018) 24
Divi's Laboratories Ltd, Ratio Charts 25
List of Tables
Divi's Laboratories Ltd, Key Facts 5
Divi's Laboratories Ltd, Key Employees 6
Divi's Laboratories Ltd, Key Employee Biographies 7
Divi's Laboratories Ltd, Major Products and Services 8
Divi's Laboratories Ltd, History 9
Divi's Laboratories Ltd, Subsidiaries 11
Divi's Laboratories Ltd, Key Competitors 19
Divi's Laboratories Ltd, Ratios based on current share price 20
Divi's Laboratories Ltd, Annual Ratios 21
Divi's Laboratories Ltd, Annual Ratios (Cont...1) 22
Divi's Laboratories Ltd, Annual Ratios (Cont...2) 23
Currency Codes 36
Capital Market Ratios 36
Equity Ratios 37
Profitability Ratios 37
Cost Ratios 38
Liquidity Ratios 38
Leverage Ratios 39
Efficiency Ratios 39
Single User License:
Corporate User License:
Piramal Enterprises Ltd
Jubilant Life Sciences Ltd
Granules India Ltd
Dishman Pharmaceuticals and Chemicals Ltd
Divi's Laboratories Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts
select a license
NEWSLETTER BY CATEGORY
The report was very informative and gives me an interesting view on the Indian market.... "Area Sales Manager, Muhlen Sohn GmbH & Co. KG"
We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help... "Group Vice President Strategy, Aliaxis"
I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again... "Technical Marketing Manager, Ascendis Health Limited"
I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ... "., Coldwell Banker - Riyadh "
The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future... "International and Business Dev. Director, Duta Abadi Primantara"